Literature DB >> 12473678

Methyl-CpG-binding protein, MeCP2, is a target molecule for maintenance DNA methyltransferase, Dnmt1.

Hiromichi Kimura1, Kunio Shiota.   

Abstract

During mammalian cell division, DNA methylation patterns are transferred accurately to the newly synthesized DNA strand. This depends on maintenance DNA methyltransferase activity. DNA methylation can affect chromatin organization and gene expression by recruitment of histone deacetylases (HDACs). Here we show that the methyl-CpG binding protein, MeCP2, interacts directly with the maintenance DNA methyltransferase, Dnmt1. The region of MeCP2 that interacts with Dnmt1 corresponds to the transcription repressor domain which can also recruit HDACs via a corepressor, mSin3A. Dnmt1 can form complexes with HDACs as well as MeCP2. Surprisingly, the MeCP2-Dnmt1 complex does not contain the histone deacetylase, HDAC1. Thus, Dnmt1 takes the place of the mSin3A-HDAC1 complex, indicating that the MeCP2-interacting Dnmt1 does not bind to HDAC1. Further, we demonstrate that MeCP2 can form a complex with hemimethylated as well as fully methylated DNA. Immunoprecipitated MeCP2 complexes show DNA methyltransferase activity to hemimethylated DNA. These results suggest that Dnmt1 associates with MeCP2 in order to perform maintenance methylation in vivo. We propose that genome-wide and/or -specific local DNA methylation may be maintained by the Dnmt1-MeCP2 complexes, bound to hemimethylated DNA. Dnmt1 may be recruited to targeted regions via multiple steps that may or may not involve histone deacetylases.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12473678     DOI: 10.1074/jbc.M209923200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  113 in total

1.  Preference of DNA methyltransferases for CpG islands in mouse embryonic stem cells.

Authors:  Naka Hattori; Tetsuya Abe; Naoko Hattori; Masako Suzuki; Tomoki Matsuyama; Shigeo Yoshida; En Li; Kunio Shiota
Journal:  Genome Res       Date:  2004-08-12       Impact factor: 9.043

2.  T-bet antagonizes mSin3a recruitment and transactivates a fully methylated IFN-gamma promoter via a conserved T-box half-site.

Authors:  Yingkai Tong; Thomas Aune; Mark Boothby
Journal:  Proc Natl Acad Sci U S A       Date:  2005-01-31       Impact factor: 11.205

3.  Aberrant regulation of epigenetic modifiers contributes to the pathogenesis in patients with selenoprotein N-related myopathies.

Authors:  Christoph Bachmann; Faiza Noreen; Nicol C Voermans; Primo L Schär; John Vissing; Johanna M Fock; Saskia Bulk; Benno Kusters; Steven A Moore; Alan H Beggs; Katherine D Mathews; Megan Meyer; Casie A Genetti; Giovanni Meola; Rosanna Cardani; Emma Mathews; Heinz Jungbluth; Francesco Muntoni; Francesco Zorzato; Susan Treves
Journal:  Hum Mutat       Date:  2019-04-01       Impact factor: 4.878

4.  Epigenetic overlap in autism-spectrum neurodevelopmental disorders: MECP2 deficiency causes reduced expression of UBE3A and GABRB3.

Authors:  Rodney C Samaco; Amber Hogart; Janine M LaSalle
Journal:  Hum Mol Genet       Date:  2004-12-22       Impact factor: 6.150

5.  MBD4 and MLH1 are required for apoptotic induction in xDNMT1-depleted embryos.

Authors:  Alexey Ruzov; Boris Shorning; Oliver Mortusewicz; Donncha S Dunican; Heinrich Leonhardt; Richard R Meehan
Journal:  Development       Date:  2009-07       Impact factor: 6.868

Review 6.  Epigenomics and breast cancer.

Authors:  Pang-Kuo Lo; Saraswati Sukumar
Journal:  Pharmacogenomics       Date:  2008-12       Impact factor: 2.533

7.  Transcriptional activation by the Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen is facilitated by an N-terminal chromatin-binding motif.

Authors:  Lai-Yee Wong; Gerald A Matchett; Angus C Wilson
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

8.  Functional characterization of the MECP2/IRAK1 lupus risk haplotype in human T cells and a human MECP2 transgenic mouse.

Authors:  Kristi A Koelsch; Ryan Webb; Matlock Jeffries; Mikhail G Dozmorov; Mark Barton Frank; Joel M Guthridge; Judith A James; Jonathan D Wren; Amr H Sawalha
Journal:  J Autoimmun       Date:  2013-02-18       Impact factor: 7.094

Review 9.  DNA methylation of cancer genome.

Authors:  Hoi-Hung Cheung; Tin-Lap Lee; Owen M Rennert; Wai-Yee Chan
Journal:  Birth Defects Res C Embryo Today       Date:  2009-12

10.  Mutant p53 binds to estrogen receptor negative promoter via DNMT1 and HDAC1 in MDA-MB-468 breast cancer cells.

Authors:  Rita Arabsolghar; Tayebeh Azimi; Mozhgan Rasti
Journal:  Mol Biol Rep       Date:  2012-12-15       Impact factor: 2.316

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.